Spain Drug Patent Inventor Report - 2011


January 1, 2012
19 Pages - SKU: THBT6770959
License type:
Table of Contents Related Reports
Countries covered: Spain

TheSpain Drug Patent Inventor Reportprofiles Spain-based inventors leading pharmaceutical innovation.

Using data on drugs approved from 2000 to 2010, this report provides complete lists of:
  • Top Inventors
  • Which inventors were granted the most patents?
  • Patents per Inventor
  • The patents awarded to each inventor Approved Drugs per Inventor
  • The approved drugs protected by each inventor's patents Co-Inventors per Inventor
  • The co-inventors listed on each inventor's patents Assignees per Inventor
  • The assignees listed on each inventor's patents



More Regulation & Policy reports by DrugPatentWatch

Drug Patent Inventor Report 2012 by DrugPatentWatch
The Drug Patent Inventor Report profiles the individuals, US states, and countries leading pharmaceutical innovation.Using data on drugs approved from 2000 to 2009, thisreport provides ...
Drug Patent Challenge Report by DrugPatentWatch
The Drug Patent Challenge Report profiles the companies that successfully challenged pharmaceutical drugs patents.Using data on drugs approved from 2000 to 2009, this report provides ...
Denmark Drug Patent Inventor Report - 2011 by DrugPatentWatch
TheDenmark Drug Patent Inventor Reportprofiles Denmark-based inventors leading pharmaceutical innovation.Using data on drugs approved from 2000 to 2010, this report provides complete lists of: Top ...
China Drug Patent Inventor Report - 2011 Publication List by DrugPatentWatch
TheChina Drug Patent Inventor Reportprofiles China-based inventors leading pharmaceutical innovation.Using data on drugs approved from 2000 to 2010, this report provides complete lists of: Top ...
See all reports like this >>

More Spain Regulation & Policy reports

Spain Pharmaceutical Market Overview – Continued stagnation as generics and price cuts erode market value by Datamonitor
IntroductionThe market environment in Spain is extremely challenging, with cost containment measures introduced in 2010–12 contributing to an overall reduction in pharmaceutical spending. The changes ...
5EU: Pricing, Reimbursement and Regulatory Update by Datamonitor
IntroductionGovernments across the five major EU markets (France, Germany, Italy, Spain, and the UK) have been busy implementing regulatory, pricing, and reimbursement reforms in 2011. ...
Pharmaceutical Pricing and Reimbursement in Spain, 2008 by Decision Resources
Introduction In recent years, Spain has rapidly increased its spending on healthcare, and pharmaceuticals account for a larger share of healthcare expenditures in Spain than ...
See all reports like this >>

More Spain reports

D&B Country RiskLine Report: Spain by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Spain by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Regulation & Policy Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!